---
title: "SMID Biotech Access Fund LP SEC filings"
url: https://altstreet.investments/edgar/2107868
kind: edgar-entity
updated: 2026-08-01
publisher: AltStreet (https://altstreet.investments)
license: Public factual pages may be read, quoted and cited with attribution and a link. Bulk redistribution is not permitted.
---

# SMID Biotech Access Fund LP: SEC filings and what they report

SMID Biotech Access Fund LP is a Delaware limited partnership filed January 29, 2026, under Rule 506(c). The fund raised $250K from 4 investors with a $50K minimum investment. It is linked to the UpMarket platform, a pre-IPO investment sponsor with 30 related EDGAR entities.

| Field | Value |
| --- | --- |
| Entity | SMID Biotech Access Fund LP |
| CIK | 2107868 |
| Filing family | 506(c) |
| Entity type | fund vehicle |
| Manager (as filed) | UpMarket |
| Platform | UpMarket (https://altstreet.investments/platforms/reviews/upmarket) |
| Newest fact-bearing filing | January 29, 2026, accession 0002107868-26-000001 |
| Total sold (as reported) | $250,000 |
| Investors (as reported) | 4 |
| Minimum investment (as filed) | $50,000 |
| Vintage | 2026 |

## Related persons (Form D Item 3)

| Name | Relationship |
| --- | --- |
| Hui Chen | Director |


## Filings (1 on record, newest first)

| Date | Form | Family | SEC link |
| --- | --- | --- | --- |
| January 29, 2026 | D | Form D | https://www.sec.gov/Archives/edgar/data/2107868/000210786826000001/ |


## More

- Entity page (HTML, with events, parties and the platform record): https://altstreet.investments/edgar/2107868
- SEC EDGAR filing index: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0002107868&owner=include&count=40
- Other issuers on UpMarket: https://altstreet.investments/deals/platform/upmarket
- Signal history, evidence passages and the entity graph are AltStreet Terminal features: https://altstreet.investments/terminal

---

Source page: https://altstreet.investments/edgar/2107868
Machine index: https://altstreet.investments/llms.txt
AltStreet reads what platforms, funds and issuers file with the SEC and what they tell investors, and publishes the difference. Figures are as filed or as captured on the date stated; nothing here is investment advice.